GlassScriptPhysician profile
Nicholas J Peiffer
NPI 1083817688
$2,871.05
in general payments reported to CMS, 2019-2025
20 companies · $638 in 2025
The $638 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $713 · 2020: $460 · 2021: $263 · 2022: $220 · 2023: $366 · 2024: $210 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.47 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $561.67 | 2019-2024 | Acclarent Aera, Trudi Nav Cable |
| Stryker Corporation | $495.40 | 2019-2025 | Clarifix |
| Medtronic, INC. | $314.87 | 2022-2025 | Propel |
| Aerin Medical INC. | $313.13 | 2019-2024 | |
| Inspire Medical Systems, INC. | $295.47 | 2023-2025 | Inspire |
| Genzyme Corporation | $189.30 | 2019-2025 | |
| Medtronic USA, INC. | $150.00 | 2020 | |
| Glaxosmithkline, LLC. | $106.92 | 2021-2025 | Nucala |
| Integra Lifesciences Corporation | $85.16 | 2024-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Neurent Medical Limited | $74.68 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Sanofi-Aventis U.S. LLC | $52.99 | 2025 | |
| Intersect Ent, INC. | $47.41 | 2021 | |
| Optinose US, INC. | $40.29 | 2019-2025 | |
| Smith+Nephew, INC. | $37.03 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $21.73 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $21.39 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Itamar Medical INC | $17.88 | 2023 | Watchpatone |
| Merck Sharp & Dohme LLC | $16.72 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.01 | 2022 | |
| Glenmark Therapeutics INC. | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Peiffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.